{
    "nctId": "NCT02400060",
    "briefTitle": "Telephone-Based Intervention in Increasing Adherence to Adjuvant Hormonal Therapy in Patients With Breast Cancer",
    "officialTitle": "Increasing Adherence to Adjuvant Hormonal Therapy Among Breast Cancer Patients: Phase 2 - Pilot Test of Intervention for Feasibility",
    "overallStatus": "RECRUITING",
    "conditions": "Stage IA Breast Cancer, Stage IB Breast Cancer, Stage IIA Breast Cancer, Stage IIB Breast Cancer, Stage IIIA Breast Cancer, Stage IIIB Breast Cancer, Stage IIIC Breast Cancer, Stage 0 Breast Cancer",
    "studyType": "INTERVENTIONAL",
    "phase": "NA",
    "allocation": "NA",
    "primaryPurpose": "SUPPORTIVE_CARE",
    "enrollmentCount": 314,
    "primaryOutcomeMeasure": "Optimal usage of AHT (includes initiation, continuation and adherence)",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Eligible women are those who:\n\n  * Are post-menopausal, verified by:\n\n    * Post bilateral surgical oophorectomy; or\n    * No spontaneous menses \\>= 1 year; or\n    * No menses for \\< 1 year with follicle stimulating hormone (FSH) and estradiol levels in postmenopausal range, according to institutional standards\n* Are diagnosed with primary breast cancer (BC) (stages I-III)\n* Eligible to receive AHT (tamoxifen or an aromatase inhibitors \\[AI\\]) for the first time\n* Completed all primary treatment\n* Own a smartphone (in order to receive text messages and utilize the phone app)\n* Agree to receive text messages on their smartphone over a 3-month period\n* Provide consent and permission to review their medical records\n* Plan to stay in the study area for 3 months",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}